11
Jul
2020
Can Novartis Digitally Transform Clinical Development?
In 2018, Dr. Vas Narasimhan, newly-installed as CEO, told the Wall Street Journal he saw Novartis as “a focused medicines company that’s powered by data science and digital technologies.” Since then, Novartis has tried to grow into this ambition, embracing the concept of digital transformation perhaps more conspicuously than any other large pharma. It’s not easy, as Narasimhan himself acknowledged... Read More